Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedExpanded the Locations section to include a comprehensive, global list of study sites across multiple countries and regions, replacing the former country/state location blocks with a consolidated sites list.SummaryDifference3%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a PubMed citation for Upadacitinib in moderate-to-severe atopic dermatitis (Am J Clin Dermatol, 2025) and removed the 'Online ahead of print' designation from the citation.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. This is a minor update related to documentation/versioning and does not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe PubMed publications note was updated to say publications are automatically filled from PubMed and may not be about the study. The revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check55 days agoChange DetectedThe government funding lapse notice banner was removed. The page now presents the study details without that disclaimer.SummaryDifference0.1%

- Check69 days agoChange DetectedThe update timestamp label changes from 'Last Update Posted' to 'Last Update Posted (Estimated)' on the page.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.